Munafa Stock Market Course + Intraday & FNO calls 
Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Karyopharm Therapeutics (KPTI)
Technical Analysis Report for NASDAQ stock KPTI Karyopharm Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics then click here. or read Experts views on Karyopharm Therapeutics or Forecast & share price targets of Karyopharm Therapeutics
Karyopharm Therapeutics Opened at 0.82 and Closed at: 0.67, which is -19.4% of previous session's close. It moved within a range of 0.63 and 0.82
The session was a Bearish session with an average volume of 1842419, which is -27.1% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 4 days back on short term averages
Support for tomorrow is 0.56 and resistance for tomorrow is 0.75
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.59, 0.52 resistance for tomorrow's hourly charts is 0.78, 0.9
10 Day SMA for Karyopharm Therapeutics (KPTI) is 1.33 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Karyopharm Therapeutics (KPTI) is 1.52 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Karyopharm Therapeutics (KPTI) is 2.17 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 5.59 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Karyopharm Therapeutics is 6.71 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Karyopharm Therapeutics is at 1.52 and 200 DMA is at 6.71, while 50 DMA and 100 DMA are at 2.17 and 5.59 respectively
Karyopharm Therapeutics (KPTI) moving average of 20 SMA is at 1.52 and 20 EMA is at 1.49
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 0.67 | 1.52 | 1.49 |
| 02 Fri Oct | 0.80 | 1.57 | 1.58 |
| 01 Thu Oct | 0.87 | 1.62 | 1.66 |
| 30 Wed Sep | 1.22 | 1.67 | 1.74 |
| 29 Tue Sep | 1.21 | 1.7 | 1.79 |
| 28 Mon Sep | 1.62 | 1.74 | 1.85 |
Karyopharm Therapeutics (KPTI) moving average of 50 SMA is at 2.17 and 50 EMA is at 2.75
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 0.67 | 2.17 | 2.75 |
| 02 Fri Oct | 0.80 | 2.31 | 2.84 |
| 01 Thu Oct | 0.87 | 2.44 | 2.92 |
| 30 Wed Sep | 1.22 | 2.56 | 3 |
| 29 Tue Sep | 1.21 | 2.68 | 3.07 |
| 28 Mon Sep | 1.62 | 2.82 | 3.15 |
Karyopharm Therapeutics (KPTI) moving average of 100 SMA is at 5.59 and 100 EMA is at 4.39
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 0.67 | 5.59 | 4.39 |
| 02 Fri Oct | 0.80 | 5.67 | 4.47 |
| 01 Thu Oct | 0.87 | 5.75 | 4.54 |
| 30 Wed Sep | 1.22 | 5.83 | 4.61 |
| 29 Tue Sep | 1.21 | 5.9 | 4.68 |
| 28 Mon Sep | 1.62 | 5.98 | 4.75 |
Karyopharm Therapeutics (KPTI) moving average of 200 SMA is at 6.71 and 200 EMA is at 5.55
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 0.67 | 6.71 | 5.55 |
| 02 Fri Oct | 0.80 | 6.74 | 5.6 |
| 01 Thu Oct | 0.87 | 6.77 | 5.65 |
| 30 Wed Sep | 1.22 | 6.79 | 5.7 |
| 29 Tue Sep | 1.21 | 6.82 | 5.75 |
| 28 Mon Sep | 1.62 | 6.85 | 5.8 |
Meridian Bioscience has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Meridian Bioscience, about 43.36% more returns!
Synergetics Usa has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Synergetics Usa, about 54.8% more returns!
Soligenix Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Soligenix Inc, about 55.79% more returns!
Uniqure N has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Uniqure N, about 11.03% more returns!
Nucana Plc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Nucana Plc, about 36.76% more returns!
Liquidia Technologies has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Liquidia Technologies, about 1.9% more returns!
Immutep has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Immutep, about 1147.16% more returns!
Gossamer Bio has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Gossamer Bio, about 5877.72% more returns!
Fennec Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 46.35% more returns!
Cytokinetics Incorporated has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 44.26% more returns!
Cellectar Biosciences has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 30.34% more returns!
Capricor Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 46.92% more returns!
Atossa Genetics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Atossa Genetics, about 58.27% more returns!
Alnylam Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 45.59% more returns!
Allogene Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 41.7% more returns!
Karyopharm Therapeutics Technical analysis of indicators
Price action analysis of Karyopharm Therapeutics (KPTI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Karyopharm Therapeutics in short term and the sell signal is strong.
Karyopharm Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Karyopharm Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Karyopharm Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.17 and Karyopharm Therapeutics KPTI stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Karyopharm Therapeutics KPTI stock. Volume based technical analysis of Karyopharm Therapeutics KPTI stock is negative.
Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And KPTI Experts View which covers a lot of information including buying and selling signals
KPTI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Karyopharm Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
